Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.27 USD | +1.79% | -15.30% | -76.93% |
Valuation
Fiscal Period: December | 2021 |
---|---|
Capitalization 1 | 315.7 |
Enterprise Value (EV) 1 | 315.3 |
P/E ratio | - |
Yield | - |
Capitalization / Revenue | - |
EV / Revenue | - |
EV / EBITDA | - |
EV / FCF | - |
FCF Yield | - |
Price to Book | -37.6 x |
Nbr of stocks (in thousands) | 31,890 |
Reference price 2 | 9.900 |
Announcement Date | 24/03/22 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 |
---|---|
Net sales | - |
EBITDA | - |
EBIT 1 | -2.8 |
Operating Margin | - |
Earnings before Tax (EBT) 1 | -2.79 |
Net income 1 | -2.79 |
Net margin | - |
EPS | - |
Free Cash Flow | - |
FCF margin | - |
FCF Conversion (EBITDA) | - |
FCF Conversion (Net income) | - |
Dividend per Share | - |
Announcement Date | 24/03/22 |
Balance Sheet Analysis
Fiscal Period: December | 2021 |
---|---|
Net Debt 1 | - |
Net Cash position 1 | 0.43 |
Leverage (Debt/EBITDA) | - |
Free Cash Flow | - |
ROE (net income / shareholders' equity) | - |
ROA (Net income/ Total Assets) | - |
Assets 1 | - |
Book Value Per Share 2 | -0.2600 |
Cash Flow per Share 2 | 0.0100 |
Capex | - |
Capex / Sales | - |
Announcement Date | 24/03/22 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- DNAC Stock
- Financials SOCL CAPI